Phase 1 Clinical Trials at John Theurer Cancer Center

Clinical trials ensure the new drug is safe to move forward into further testing in larger groups of people. They test new cancer treatments for safety and determine the best dose for patients and are the first step in bringing innovative therapies to cancer patients who may not have other treatment options.

Goals of Phase 1 Trials

Phase 1 trials focus mainly on safety and dosage rather than testing how well the treatment works; however, there are many patients whose disease will respond to Phase I Trial therapies. The primary goals of conducting phase 1 clinical trials are:

To evaluate the safety of a new drug or treatment and identify any potential side effects.
To determine the best dose of the treatment that is both safe and effective without causing harmful effects.
To understand how the drug is absorbed, distributed, metabolized, and eliminated by the body.
To study the drug's effect on the body and its mechanism of action.

How Phase 1 Trials Help Patients

At John Theurer Cancer Center, you benefit from one of the nation’s leading phase 1 clinical research programs. Representing nearly one third of our cancer research, phase 1 clinical trials allow our patients to receive exciting and innovative cancer therapies before anyone else. We conduct more clinical trials than any other cancer center in NJ. If selected for a phase 1 clinical trial, you will receive discounted or no-cost care, and some studies even offer reimbursement. We're committed to making our clinical trials available to all cancer patients, regardless of race and ethnicity.

How to Participate

Review our Phase 1 clinical trials below, and if you find one interesting and / or fit the inclusion criteria, please reach out via the information contained within that posting. If you have a general interest in participating, you can call us directly at 551-996-1777.